Auto-reactivity against gut bacterial peptides in patients with late-onset diabetes

References

• Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281.
   PubMed Web of Science ®Google Scholar
• de Candia P, Prattichizzo F, Garavelli S, et al. Type 2 diabetes: how much of an autoimmune disease? Front Endocrinol. 2019;10:451.
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care. 2001;24(8):1460–1467.
   PubMed Web of Science ®Google Scholar
• Chiu HK, Tsai EC, Juneja R, et al. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients. Diabetes Res Clin Pract. 2007;77(2):237–244.
   PubMed Web of Science ®Google Scholar
• Zhong D, Wu C, Zeng X, et al. The role of gut microbiota in the pathogenesis of rheumatic diseases. Clin Rheumatol. 2018;37(1):25–34.
   PubMed Web of Science ®Google Scholar
• Duc D, Vigne S, Bernier-Latmani J, et al. Disrupting myelin-specific Th17 cell gut homing confers protection in an adoptive transfer experimental autoimmune encephalomyelitis. Cell Rep. 2019;29(2):378.e4–390.e4.
   Web of Science ®Google Scholar
• Azzouz D, Omarbekova A, Heguy A, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78(7):947–956.
   PubMed Web of Science ®Google Scholar
• Giongo A, Gano KA, Crabb DB, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011;5(1):82–91.
   PubMed Web of Science ®Google Scholar
• Zheng P, Li Z, Zhou Z. Gut microbiome in type 1 diabetes: a comprehensive review. Diabetes Metab Res Rev. 2018;34(7):e3043.
   PubMed Web of Science ®Google Scholar
• Chang H-W, Yan D, Singh R, et al. Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization. Microbiome. 2018;6(1):154.
   PubMedGoogle Scholar
• Vallianou NG, Stratigou T, Tsagarakis S. Microbiome and diabetes: where are we now? Diabetes Res Clin Pract. 2018;146:111–118.
   PubMed Web of Science ®Google Scholar
• Atarashi K, Honda K. Microbiota in autoimmunity and tolerance. Curr Opin Immunol. 2011;23(6):761–768.
   PubMed Web of Science ®Google Scholar
• Wu H-J, Ivanov II, Darce J, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32(6):815–827.
   PubMed Web of Science ®Google Scholar
• Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538–541.
   PubMed Web of Science ®Google Scholar
• Tai N, Peng J, Liu F, et al. Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice. J Exp Med. 2016;213(10):2129–2146.
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004;4(6):478–485.
   PubMed Web of Science ®Google Scholar
• Man AL, Gicheva N, Nicoletti C. The impact of ageing on the intestinal epithelial barrier and immune system. Cell Immunol. 2014;289(1–2):112–118.
   PubMed Web of Science ®Google Scholar
• Rera M, Clark RI, Walker DW. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc Natl Acad Sci USA. 2012;109(52):21528–21533.
   PubMed Web of Science ®Google Scholar
• Qi Y, Goel R, Kim S, et al. Intestinal permeability biomarker zonulin is elevated in healthy aging. J Am Med Dir Assoc. 2017;18(9):810.e1–810.e4.
   Web of Science ®Google Scholar
• Negi S, Singh H, Mukhopadhyay A. Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: in-silico study. PLoS One. 2017;12(7):e0180518.
   PubMed Web of Science ®Google Scholar
• Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics. 2001;17(12):1236–1237.
   PubMed Web of Science ®Google Scholar
• Singh H, Raghava GPS. ProPred1: prediction of promiscuous MHC class-I binding sites. Bioinformatics. 2003;19(8):1009–1014.
   PubMed Web of Science ®Google Scholar
• Velumani S, Ho H-T, He F, et al. A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One. 2011;6(6):e20737.
   PubMed Web of Science ®Google Scholar
• Pham MN, Hawa MI, Pfleger C, et al. Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: action LADA 4. Diabetologia. 2011;54(7):1630–1638.
   PubMed Web of Science ®Google Scholar
• Murri M, Leiva I, Gomez-Zumaquero JM, et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013;11:46.
   PubMed Web of Science ®Google Scholar
• Real-Fernandez F, Passalacqua I, Peroni E, et al. Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance. Sensors. 2012;12(5):5596–5607.
   PubMed Web of Science ®Google Scholar
• van Woudenbergh GJ, Kuijsten A, Sijbrands EJG, et al. Glycemic index and glycemic load and their association with C-reactive protein and incident type 2 diabetes. J Nutr Metab. 2011;2011:623076.
   PubMedGoogle Scholar
• Brophy S, Davies H, Stephens JW, et al. Adiponectin levels in people with latent autoimmune diabetes-a case control study. BMC Res Notes. 2010;3:317.
   PubMedGoogle Scholar
• Yun JE, Sull JW, Lee HY, et al. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients. Diabetes Metab Res Rev. 2009;25(3):259–265.
   PubMed Web of Science ®Google Scholar
• Marques-Vidal P, Bastardot F, von Kanel R, et al. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol. 2013;78(2):232–241.
   PubMed Web of Science ®Google Scholar
• Mu Q, Kirby J, Reilly CM, et al. Leaky gut as a danger signal for autoimmune diseases. Front Immunol. 2017;8:598–598.
   PubMed Web of Science ®Google Scholar
• Sorini C, Cosorich I, Lo Conte M, et al. Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes. Proc Natl Acad Sci USA. 2019;116(30):15140–15149.
   PubMed Web of Science ®Google Scholar
• Bosi E, Molteni L, Radaelli MG, et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia. 2006;49(12):2824–2827.
   PubMed Web of Science ®Google Scholar
• Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med. 2009;360(16):1646–1654.
   PubMed Web of Science ®Google Scholar
• Vehik K, Dabelea D. The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev. 2011;27(1):3–13.
   PubMed Web of Science ®Google Scholar
• Myers MA, Hettiarachchi KD, Ludeman JP, et al. Dietary microbial toxins and type 1 diabetes. Ann N Y Acad Sci. 2003;1005:418–422.
   PubMed Web of Science ®Google Scholar
• Patterson E, Ryan PM, Cryan JF, et al. Gut microbiota, obesity and diabetes. Postgrad Med J. 2016;92(1087):286–300.
   PubMed Web of Science ®Google Scholar
• Li X, Atkinson MA. The role for gut permeability in the pathogenesis of type 1 diabetes-a solid or leaky concept? Pediatr Diabetes. 2015;16(7):485–492.
   PubMed Web of Science ®Google Scholar
• Hammond LE, Neschen S, Romanelli AJ, et al. Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs. J Biol Chem. 2005;280(27):25629–25636.
   PubMed Web of Science ®Google Scholar
• Croxford JL, Anger HA, Miller SD. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry. J Immunol. 2005;174(2):907–917.
   PubMed Web of Science ®Google Scholar
• Classen JB, Classen DC. Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM. Autoimmunity. 2002;35(4):247–253.
   PubMed Web of Science ®Google Scholar
• Chen J, Chia N, Kalari KR, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. 2016;6:28484.
   PubMed Web of Science ®Google Scholar
• Santamaría E, Avila MA, Latasa MU, et al. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Nat Acad Sci. 2003;100(6):3065–3070.
   PubMed Web of Science ®Google Scholar
• Wijekoon EP, Hall B, Ratnam S, et al. Homocysteine metabolism in ZDF (type 2) diabetic rats. Diabetes. 2005;54(11):3245–3251.
   PubMed Web of Science ®Google Scholar
• Moon MK, Kim M, Chung SS, et al. S-Adenosyl-L-methionine ameliorates TNFalpha-induced insulin resistance in 3T3-L1 adipocytes . Exp Mol Med. 2010;42(5):345–352.
   PubMed Web of Science ®Google Scholar
• Gomez A, Luckey D, Yeoman CJ, et al. Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PloS One. 2012;7(4):e36095.
   PubMed Web of Science ®Google Scholar
• Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60.
   PubMed Web of Science ®Google Scholar
• Chen S, Akter S, Kuwahara K, et al. Serum amino acid profiles and risk of type 2 diabetes among Japanese adults in the Hitachi Health Study. Sci Rep. 2019;9(1):7010.
   PubMedGoogle Scholar
• Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103.
   PubMed Web of Science ®Google Scholar
• Larsen N, Vogensen FK, van den Berg FWJ, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS One. 2010;5(2):e9085.
   PubMed Web of Science ®Google Scholar
• Tonucci LB, Olbrich Dos Santos KM, De Luces Fortes Ferreira CL, et al. Gut microbiota and probiotics: focus on diabetes. Autoimmunity. 2017;57(11):2296–2309.
   Google Scholar
• Balakrishnan B, Taneja V. Microbial modulation of the gut microbiome for treating autoimmune diseases. Autoimmunity. 2018;12(10):985–996.
   Google Scholar